Computerized Clinical Pharmacy Management System Improves Prescribing Quality and Rational Antimicribial Use
American Journal of Internal Medicine
Volume 4, Issue 6, November 2016, Pages: 107-112
Received: Nov. 22, 2016; Published: Nov. 24, 2016
Views 2572      Downloads 61
Authors
Xianhua Ren, Department of Pharmacy, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, People’s Republic of China
Quansheng Ren, Department of Pharmacy, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, People’s Republic of China
Article Tools
Follow on us
Abstract
To introduce the increased efficiency and improved health care provision brought by incorporating a certified clinical pharmacy management (CPM) system into an existing hospital information system. Evaluate the appropriateness rate of prescriptions or orders, the rational use of antimicrobial use, and the workflow of clinical pharmacist before and after the adoption of the CPM system. The adoption of the CPM system markedly increased the appropriateness rate of prescriptions and orders by 89% in 2011 as compared to that of 2010. The CPMS decrease the antimicrobial use both in outpatients and inpatients by 47.0% and 51.9 respectively in December 2011 as compared to that of January 2011. The CPMS also streamlined the clinical pharmacist’s workflow and help disseminate medication use knowledge and policies within the hospital.
Keywords
Clinical Pharmacy Management System, Prescribing Appropriateness Rate, Rational Antimicrobial Use
To cite this article
Xianhua Ren, Quansheng Ren, Computerized Clinical Pharmacy Management System Improves Prescribing Quality and Rational Antimicribial Use, American Journal of Internal Medicine. Vol. 4, No. 6, 2016, pp. 107-112. doi: 10.11648/j.ajim.20160406.13
References
[1]
The role of the pharmacist in the health care system. Preparing the future pharmacist: Curricular development. Report of a third WHO Consultative Group on the role of the pharmacist, Vancouver, Canada, 27–29 August 1997. Geneva: World Health Organization; 1997. WHO/PHARM/97/599. Available at: http://www.who.int/medicinedocs/.
[2]
State Council of the People’s Republic of China (2002) Regulations on pharmacy administration in medical organizations (trial, in Chinese). State Council Document 2002(24). Beijing: State Council. Available: http://www.satcm.gov.cn/web2010/zhengw. ugongkai/zhengcefagui/falvfagui/guizhang/2010-10-07/9326.html. Accessed 11 January 2012.
[3]
State Council of the People’s Republic of China (2011) Regulations on pharmacy administration in medical organizations (in Chinese). Beijing: State Council. State Council Document 2011(11). Available: http://www.satcm.gov.cn/web2010/zhengwugon. gkai/zhengcefagui/falvfagui/guizhang/2011-04-07/13297.html. Accessed 11 January 2012.
[4]
State Council of the People’s Republic of China (2009) National Essential Medicine List (in Chinese). Beijing: State Council. State Council Document 2009(69). Available: http://www.gov.cn/gzdt/2009-08/18/content_1395524.htm. Accessed 15 January 2012.
[5]
State Council of the People’s Republic of China (2003) Chinese National Formulary (in Chinese). Beijing: State Council.
[6]
State Council of the People’s Republic of China (2010) Regulations on prescribing evaluation in hospitals (trial, in Chinese). Beijing: State Council. State Council Document 2010(28). Available: http://www.gov.cn/gzdt/2010-03/04/content_1547080.htm. Accessed 14 January 2012.
[7]
State Council of the People’s Republic of China (2004) Principles of clinical antimicrobial usage (in Chinese). Beijing: State Council. State Council Document 2004(285). Available: http://www.moh.gov.cn/publicfiles/business/cmsresources/mohylfwjgs/cmsrsdocument/doc5285.doc. Accessed 15 January 2012.
[8]
State Council of the People’s Republic of China (2009 November) Guidelines for perioperative prophylactic treatment (in Chinese). Beijing: State Council. Available: http://www.moh.gov.cn/publicfiles///business/cmsresources/mohylfwjgs/cmsrsdocument/doc6647.doc. Accessed 15 January 2012.
[9]
State Council of the People’s Republic of China (2009 November) Principles of perioperative prophylactic treatment in clean surgeries (in Chinese). Beijing: State Council. Available: http://www.moh.gov.cn/publicfiles///business/cmsresources/mohylfwjgs/cmsrsdocument/doc6647.doc. Accessed 15 January 2012.
[10]
State Council of the People’s Republic of China (2007) Regulations on prescribing management (in Chinese). Beijing: State Council. State Council Document 2007 (53). Available: http://www.gov.cn/flfg/2007-03/13/content_549406.htm. Accessed 14 January 2012.
[11]
State Council of the People’s Republic of China (2011) Regulations on clinical antimicrobial utilizaiton (trial, in Chinese). Beijing: State Council. State Council Document 2011 (75). Available: http://bmyj.chinalaw.gov.cn/lismsPro/law_download/fulltext/1312360890480.doc. Accessed 15 January 2012.
[12]
Wessling, A. and G. Boethius, Measurement of drug use in a defined population. Evaluation of the defined daily dose (DDD) methodology. Eur J Clin Pharmacol, 1990. 39 (3): p. 207-10.
[13]
Zhang R, Eggleston K, Rotimi V, Zeckhauser RJ. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health 2006; 2: 6.
[14]
World Health Organization (2003) Drug and therapeutics committee: a practical guide. Geneva: World Health Organization.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186